Skip to content

Homeopathic treatment of seizures in children

Efficacy of individualised homeopathic medicines in treatment of paediatric epilepsy: a double-blind, randomised, placebo-controlled trial in mutual context of usual care

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/10/016027
Enrollment
60
Registered
2018-10-15
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G403- Generalized idiopathic epilepsy and epileptic syndromes

Interventions

Intervention1: Homeopathic individualised medicines in centesimal potencies: Intervention is planned as administering indicated homeopathic medicines in centesimal potencies. Each dose consists of 4-6
dosage and repetition depending upon the individual requirement of the cases. All medicines will be procured from a Good Manufacturing Practice (GMP)- certified firm. Along with the medicines, the int
dosage and repetition depending upon the individual requirement of the cases. Duration of therapy: 6 months.

Sponsors

National Institute of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a) Cases suffering from epilepsy for at least 3 months b) Both male and female patients c) Age between 4 and 18 years d) Patients with seizure frequency of at least once in three months e) Capability and willingness to give informed consent by the parents and to comply with the study procedures f) Literate parents who can read English and/or Bengali

Exclusion criteria

Exclusion criteria: a) Patients with febrile convulsions b) Patients with intractable epilepsy c) Patients with co-morbidity, like - ADHD, mental retardation d) A clinically significant acute or chronic disease that would hinder regular participation in the study e) Patients who are not on anti-epileptic drugs f) Complementary or alternative treatment used simultaneously to the study (for example acupuncture, psychotherapy etc.) g) Homeopathic treatment for at least eight weeks for any chronic diseases h) Cases suffering from uncontrolled systemic illness or life-threatening infections i) Self-reported immune-compromised state j) Patients with substance abuse and/or dependence

Design outcomes

Primary

MeasureTime frame
Hague Seizure Severity Scale (HASS) measures severity of childhood epilepsyTimepoint: At baseline, after 3 months, and after 6 months

Secondary

MeasureTime frame
Pediatric Quality of Life Inventory (PedsQL) measures health-related quality of life (HRQOL) in healthy children and adolescents and those with acute and chronic health conditionsTimepoint: At baseline, after 3 months, and after 6 months;Quality of life in Childhood Epilepsy (QOLCE-16) measure of health-related quality of life (HRQoL)Timepoint: At baseline, after 3 months, and after 6 months

Countries

India

Contacts

Public ContactGautam Ash

National Institute of Homoeopathy

dr.gautam.ash01@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 10, 2026